Quick Takeaways
- AGENUS INC has 1 issuer position tracked on this page.
- Estimated disclosed ownership value: $22,643,778.
- Recent insider filing activity is available below.
Insider Trading & Ownership of AGENUS INC
- Location
- Lexington, MA
- Summary
- The estimated value of insider holdings of AGENUS INC is at least $22,643,778 dollars as of 16 Oct 2023. AGENUS INC is the 10%+ Owner of MiNK Therapeutics, Inc. and owns shares of MiNK Therapeutics, Inc. (INKT) stock worth about $22.64M.
- Signature
- /s/Christine Klaskin, Vice President, Finance
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow AGENUS INC and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.
What Changed
- Largest disclosed position: MiNK Therapeutics, Inc. ($22,643,778).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of AGENUS INC
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| INKT | MiNK Therapeutics, Inc. | 10%+ Owner | $22,643,778 | 12 Oct 2023 |
Insider Transactions Reported by AGENUS INC:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.